Cancer Biomarkers

Cancer biomarker alludes to a substance or process that is demonstrative of the potency of generation of tumor in the body. A biomarker might be a particle emitted by a tumor or a particular reaction of the body in the vicinity of disease. Hereditary, epigenetic, proteomic, glycomic and imaging biomarkers can be utilized for malignancy determination, anticipation and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-obtrusively gathered bio-fluids like blood or serum.

 

  • Diagnostic Biomarkers
  • Tumour Suppressors Biomarkers
  • Prognosis, Screening and treatment predictions
  • Monitoring treatment response

Related Conference of Cancer Biomarkers

November 25-26, 2020

39th World Cancer Conference

Rome, Italy
November 26-27, 2020

4th Global Summit on Cancer Science and Oncology

Vienna, Austria
December 07-08, 2020

2nd Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
December 10-11, 2020

4th Annual Conference on Skin Cancer and Dermatology

Abu Dhabi, UAE
April 28-29, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
May 17-18, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
May 17-18, 2021

11th World Congress on Breast Cancer & Therapies

Prague, Czech Republic
June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Australia
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
August 13-14, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany

Cancer Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in